JP2013530157A5 - - Google Patents

Info

Publication number

JP2013530157A5

JP2013530157A5 JP2013512250A JP2013512250A JP2013530157A5 JP 2013530157 A5 JP2013530157 A5 JP 2013530157A5 JP 2013512250 A JP2013512250 A JP 2013512250A JP 2013512250 A JP2013512250 A JP 2013512250A JP 2013530157 A5 JP2013530157 A5 JP 2013530157A5

Authority

JP

Japan

Prior art keywords

adjuvant

agonist

composition

tlr

cell antigen

Prior art date

2011-05-26

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000002671 adjuvant Substances 0.000 claims 33
• 239000000427 antigen Substances 0.000 claims 30
• 102000036639 antigens Human genes 0.000 claims 30
• 108091007433 antigens Proteins 0.000 claims 30
• 239000000203 mixture Substances 0.000 claims 24
• 239000002539 nanocarrier Substances 0.000 claims 17
• 239000000556 agonist Substances 0.000 claims 13
• 239000002105 nanoparticle Substances 0.000 claims 9
• 229940037003 alum Drugs 0.000 claims 6
• 210000003719 b-lymphocyte Anatomy 0.000 claims 6
• 210000002443 helper t lymphocyte Anatomy 0.000 claims 6
• 108020004707 nucleic acids Proteins 0.000 claims 6
• 102000039446 nucleic acids Human genes 0.000 claims 6
• 150000007523 nucleic acids Chemical class 0.000 claims 6
• 210000001744 T-lymphocyte Anatomy 0.000 claims 5
• SQQXRXKYTKFFSM-UHFFFAOYSA-N chembl1992147 Chemical compound OC1=C(OC)C(OC)=CC=C1C1=C(C)C(C(O)=O)=NC(C=2N=C3C4=NC(C)(C)N=C4C(OC)=C(O)C3=CC=2)=C1N SQQXRXKYTKFFSM-UHFFFAOYSA-N 0.000 claims 5
• 229940124669 imidazoquinoline Drugs 0.000 claims 5
• 229920000642 polymer Polymers 0.000 claims 4
• 229950010550 resiquimod Drugs 0.000 claims 4
• BXNMTOQRYBFHNZ-UHFFFAOYSA-N resiquimod Chemical compound C1=CC=CC2=C(N(C(COCC)=N3)CC(C)(C)O)C3=C(N)N=C21 BXNMTOQRYBFHNZ-UHFFFAOYSA-N 0.000 claims 4
• SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 3
• GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 3
• 102000002689 Toll-like receptor Human genes 0.000 claims 3
• 108020000411 Toll-like receptor Proteins 0.000 claims 3
• 229960002715 nicotine Drugs 0.000 claims 3
• SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims 3
• 229920000747 poly(lactic acid) Polymers 0.000 claims 3
• 230000009885 systemic effect Effects 0.000 claims 3
• 229920000954 Polyglycolide Polymers 0.000 claims 2
• 229940124614 TLR 8 agonist Drugs 0.000 claims 2
• 239000000839 emulsion Substances 0.000 claims 2
• 230000003308 immunostimulating effect Effects 0.000 claims 2
• 208000015181 infectious disease Diseases 0.000 claims 2
• 238000000034 method Methods 0.000 claims 2
• 239000002245 particle Substances 0.000 claims 2
• 229920001610 polycaprolactone Polymers 0.000 claims 2
• 239000004632 polycaprolactone Substances 0.000 claims 2
• 229920000728 polyester Polymers 0.000 claims 2
• 229920000570 polyether Polymers 0.000 claims 2
• 108090000765 processed proteins & peptides Proteins 0.000 claims 2
• 229940044601 receptor agonist Drugs 0.000 claims 2
• 239000000018 receptor agonist Substances 0.000 claims 2
• DRHZYJAUECRAJM-DWSYSWFDSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-8a-[(2s,3r,4s,5r,6r)-3-[(2s,3r,4s,5r,6s)-5-[(2s,3r,4s,5r)-4-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-5-[(3s,5s, Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2[C@@]1(C=O)C)O)C(=O)O[C@@H]1O[C@H](C)[C@@H]([C@@H]([C@H]1O[C@H]1[C@@H]([C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@](O)(CO)CO3)O)[C@H](O)CO2)O)[C@H](C)O1)O)O)OC(=O)C[C@@H](O)C[C@H](OC(=O)C[C@@H](O)C[C@@H]([C@@H](C)CC)O[C@H]1[C@@H]([C@@H](O)[C@H](CO)O1)O)[C@@H](C)CC)C(O)=O)[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O DRHZYJAUECRAJM-DWSYSWFDSA-N 0.000 claims 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims 1
• YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims 1
• 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 claims 1
• 206010003645 Atopy Diseases 0.000 claims 1
• 101710158075 Bucky ball Proteins 0.000 claims 1
• XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 claims 1
• 229940123189 CD40 agonist Drugs 0.000 claims 1
• 101710098119 Chaperonin GroEL 2 Proteins 0.000 claims 1
• 102000009016 Cholera Toxin Human genes 0.000 claims 1
• 108010049048 Cholera Toxin Proteins 0.000 claims 1
• 208000035473 Communicable disease Diseases 0.000 claims 1
• 108090000695 Cytokines Proteins 0.000 claims 1
• 102000004127 Cytokines Human genes 0.000 claims 1
• YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 claims 1
• 102000009109 Fc receptors Human genes 0.000 claims 1
• 108010087819 Fc receptors Proteins 0.000 claims 1
• 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 claims 1
• 102100037850 Interferon gamma Human genes 0.000 claims 1
• 108010074328 Interferon-gamma Proteins 0.000 claims 1
• 108010050904 Interferons Proteins 0.000 claims 1
• 102000014150 Interferons Human genes 0.000 claims 1
• 108090001005 Interleukin-6 Proteins 0.000 claims 1
• 108010063738 Interleukins Proteins 0.000 claims 1
• 102000015696 Interleukins Human genes 0.000 claims 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 1
• 101100481584 Mus musculus Tlr1 gene Proteins 0.000 claims 1
• 206010028980 Neoplasm Diseases 0.000 claims 1
• 108010058846 Ovalbumin Proteins 0.000 claims 1
• 229910019142 PO4 Inorganic materials 0.000 claims 1
• 208000037581 Persistent Infection Diseases 0.000 claims 1
• 239000002202 Polyethylene glycol Substances 0.000 claims 1
• 230000029662 T-helper 1 type immune response Effects 0.000 claims 1
• 229940124615 TLR 7 agonist Drugs 0.000 claims 1
• BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims 1
• 229940123384 Toll-like receptor (TLR) agonist Drugs 0.000 claims 1
• 102100039360 Toll-like receptor 4 Human genes 0.000 claims 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
• 229930003427 Vitamin E Natural products 0.000 claims 1
• UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 claims 1
• 239000002253 acid Substances 0.000 claims 1
• -1 alum Chemical class 0.000 claims 1
• 208000006673 asthma Diseases 0.000 claims 1
• 230000015572 biosynthetic process Effects 0.000 claims 1
• 201000011510 cancer Diseases 0.000 claims 1
• 230000001413 cellular effect Effects 0.000 claims 1
• 102000006834 complement receptors Human genes 0.000 claims 1
• 108010047295 complement receptors Proteins 0.000 claims 1
• 229920001577 copolymer Chemical compound 0.000 claims 1
• 239000000409 cytokine receptor agonist Substances 0.000 claims 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 1
• 239000000412 dendrimer Substances 0.000 claims 1
• 229920000736 dendritic polymer Polymers 0.000 claims 1
• PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims 1
• 239000002552 dosage form Substances 0.000 claims 1
• 239000003995 emulsifying agent Substances 0.000 claims 1
• 238000005538 encapsulation Methods 0.000 claims 1
• LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 1
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
• 230000028996 humoral immune response Effects 0.000 claims 1
• 229920001477 hydrophilic polymer Polymers 0.000 claims 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
• 229960002751 imiquimod Drugs 0.000 claims 1
• DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 claims 1
• 230000028709 inflammatory response Effects 0.000 claims 1
• 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
• 229940079322 interferon Drugs 0.000 claims 1
• 235000014655 lactic acid Nutrition 0.000 claims 1
• 239000004310 lactic acid Substances 0.000 claims 1
• 150000002632 lipids Chemical group 0.000 claims 1
• 239000002502 liposome Substances 0.000 claims 1
• 239000002082 metal nanoparticle Substances 0.000 claims 1
• 230000000813 microbial effect Effects 0.000 claims 1
• 239000011707 mineral Substances 0.000 claims 1
• 229940035032 monophosphoryl lipid a Drugs 0.000 claims 1
• BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 claims 1
• 239000002086 nanomaterial Substances 0.000 claims 1
• 239000002070 nanowire Substances 0.000 claims 1
• 229940092253 ovalbumin Drugs 0.000 claims 1
• 239000000546 pharmaceutical excipient Substances 0.000 claims 1
• 239000010452 phosphate Substances 0.000 claims 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
• 229920001223 polyethylene glycol Polymers 0.000 claims 1
• 230000002265 prevention Effects 0.000 claims 1
• 102000004169 proteins and genes Human genes 0.000 claims 1
• 108090000623 proteins and genes Proteins 0.000 claims 1
• 239000001397 quillaja saponaria molina bark Substances 0.000 claims 1
• 230000004044 response Effects 0.000 claims 1
• 150000003839 salts Chemical class 0.000 claims 1
• 229930182490 saponin Natural products 0.000 claims 1
• 150000007949 saponins Chemical class 0.000 claims 1
• 229940031439 squalene Drugs 0.000 claims 1
• TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims 1
• 239000004094 surface-active agent Substances 0.000 claims 1
• 208000024891 symptom Diseases 0.000 claims 1
• 238000003786 synthesis reaction Methods 0.000 claims 1
• 229930003799 tocopherol Natural products 0.000 claims 1
• 235000010384 tocopherol Nutrition 0.000 claims 1
• 229960001295 tocopherol Drugs 0.000 claims 1
• 239000011732 tocopherol Substances 0.000 claims 1
• 229940044616 toll-like receptor 7 agonist Drugs 0.000 claims 1
• 239000011709 vitamin E Substances 0.000 claims 1
• 229940046009 vitamin E Drugs 0.000 claims 1
• 235000019165 vitamin E Nutrition 0.000 claims 1
• GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 1